chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT STATES ABOUT FIVE MINUTES AFTER HE RECEIVED HIS VACCINE HE STARTED TO FEEL LIKE HE WAS GOING TO PASS OUT. HE BECAME NAUSEOUS, DIZZY AND EXTREMELY DIAPHORETIC. HE DID NOT PASS OUT. HE JUST HAD SYMPTOMS. WE GAVE HIM SOME APPLE JUICE AND GRAHAM CRACKERS. HE WAS FEELING BETTER ALMOST IMMEDIATELY.
6 cm red rash with pain and swelling; fever at injection site; cough, red throat; post-nasal drip; bruising - treated with ZITHROMAX antibiotic; cough syrup; BENADRYL; ZYRTEC and icing- lasted one week +
Skin rash at site x one week. lethargy x 2 episodes of vomiting lasting 7d began 5 to 7 days after administration. hives-mild case comes and goes x one week
Fever, chills, and sore arm started about 15 hours after receiving the vaccine, and lasted about 18 hours
Tired, headache, fever, chills, body aches, started the morning after the shot, lasted for one day.
red rashes after 1st dose but not on injection site below the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH ERYTHEMATOUS (red rashes after 1st dose but not on injection site below the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (red rashes after 1st dose but not on injection site below the injection site). At the time of the report, RASH ERYTHEMATOUS (red rashes after 1st dose but not on injection site below the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter No treatment medications provided by the reporter.
Tdap imm 2-19-15. Injection site red, hot, itchy, inflammed 6.5 cm hard  area of induration. Significant malaise.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25May2022 at 17:30 as dose 4 (booster), single (Lot number: FM7553) at the age of 66 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), on 27Jan2021 as dose 1, single (Lot number: 043L20A), in left arm, on 24Feb2021 as dose 2, single (Lot number: 001A21A), in left arm and on 29Dec2021 at 19:00 as dose 3 (booster), single (Lot number: 065F21A), in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SERTRALINE; BUPROPION. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Jul2022) Negative, notes: tested antigen negative on 07Jul; (unspecified date) Unknown results, notes: Treatment of COVID-19; (09Jul2022) Positive, notes: recurrent symptoms and positive test on 09Jul. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid from 30Jun2022 to 04Jul2022.; Sender's Comments: Based on the known safety profile of the vaccine  BNT162b2, a causal relation between the reported events Covid-19, Drug ineffective and the administration of the vaccine cannot be excluded.
Vaccine was mixed incorrectly.  Not enough diluent was added to the COVID vaccine.
The following day I took off of work for the typical symptoms and I recovered within 48 hours. Around the middle of March, the right side of my face hurt and felt like there was electricity shooting through it, and I noticed a sore developing above my lip. As my symptoms worsened with a terrible headache, I used my telehealth service and uploaded a picture of my face and they diagnosed me with Shingles and gave me antiviral medications and it cleared within a week. About 6 months later in August 2021, I had a recurrence in the same spot but it was mild, and I haven't had another incident since.
chills; fatigue; migraine-like headaches; dizziness; nausea; migraine-like headache and fatigue severe enough to prevent normal activity; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3247), intramuscularly into the left arm on 28Jan2021 14:15 at a single dose for COVID-19 immunisation. Medical history included Polycystic ovarian syndrome (PCOS), depression, obesity and allergies to latex. Patient was not pregnant. Concomitant medication included duloxetine hydrochloride (CYMBALTA), bupropion hydrochloride (WELLBUTRIN), colecalciferol (VITAMIN D) and cyanocobalamin (VITAMIN B12). The patient previously took tetracycline and experienced drug allergy. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EJ1685), intramuscularly into the right arm on 06Jan2021 03:15 PM at a single dose for COVID-19 immunisation. On 28Jan2021 20:00, patient experienced chills, fatigue, migraine-like headaches, dizziness, nausea and migraine-like headache and fatigue severe enough to prevent normal activity. The events were reported as non-serious. The patient did not receive any treatment for the events reported. Outcome of events was unknown.
When the student nurse injected the child the first time,  there was significant spilling and less than half the dose was administered. The student withdrew the needle and attempted a 2nd time with another loaded syringe. However, she felt resistance and unable to inject the vaccine, so she withdrew the needle without giving any vaccine. Her partner saw that, and helped her administered a full dose (0.2 ml) with another loaded syringe.    The child received 3 pokes at her left arm, and one full dose was delivered.
patient received 1st dose of Moderna COVID vaccine on 2/5/2021.    On 2/11/2021 patient developed body aches, cough, headache, nasal congestion.  COVID test positive.
Pt developed L eye vision changes on 3/17/2021 but did not seek medication attention until 3/22 when he saw ophthalmology and was advised to go immediately to ER.  After a temporal artery biopsy to r/o temporal arteritis and head/brain imaging studies, he was diagnosed with  non-arteritic anterior ischemic optic neuropathy.  He was treated and discharged home with close follow up.  On 4/5/2021, he developed hematuria and was again hospitalized and found to have an obstructing L ureteral stone. Pt was hospitalized 3 days for first issue, 7 days for second issue.
On July 29, 2022, five days after receiving my 2nd Covid Booster (received on July 24, 2022), I started to experience double vision while driving and extreme eye fatigue.  The double vision then persistent while simply looking at a distance, while walking, watching television, and computer work. I contacted my ophthalmologist who diagnosed me with strabismus (appt was during the week of August 22, exact day not remembered as they gave me an appointment almost immediately due to my symptoms) and planned to refer me to a specialist. That referral was never processed therefore I consulted with my primary care physician who processed a referral to Neuro-Ophthalmologist.  By the time I was able to be seen by Dr., it was 10/26/2022.  Prior to receiving the 2nd Covid Booster, I did not have any vision issues.  My only vision prescription was a progressive prescription for reading and computer only.  This 2nd booster was also the only vaccine that also caused the chills and headache the following day and I was unable to go to work.
Information has been received from a registered nurse concerning a male with no medical history or allergies who on 31 Oct 2006 was vaccinated with PO with a dose of rotavirus vaccine. Concomitant vaccinations administered on that same day included a dose of Hib (manufacturer unknown), a dose of poliovirus vaccine (unspecified), a dose of Prevnar and a dose of Dtap. The RN reported that on 07 Nov 2006, the patient was seen in the physicians office because he had become fussy and very irritable, and had developed a fever and diarrhea. At the time of this report, the outcome was unknown. Additional information has been requested.
My daughter received Meningitis, Hepatitis A, and HPV vaccines. [First injection for each of these for her...I know HPV and one of the others requires booster(s).]  Less than a minute after receiving injections and while still sitting on exam table, my daughter fainted and had short episode of seizure-type activity...shaking and her eyes rolled.  Vital signs monitored and oxygen was administered.
Patient states she started having adverse effects just prior to midnight after receiving her 4 vaccinations earlier in the day.  She stated she is so sick, said she feels like she has flu and Covid both. Patient states both arms hurt, headache, sore throat, fever, constantly urinating, and could not sleep all night last night.   Patient was advised to call her Dr and she did not want to.
scared it can be an allergic reaction; this morning it is a little swollen, her left eye; Headache; night her eye kind of hurt, it felt like a stye coming; night her eye kind of hurt, it felt like a stye coming; crying; scared; This is a spontaneous report from a contactable consumer (reported for herself). A 27-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: unknown) via an unspecified route of administration, administered in arm left on 18Jul2021 11:30 (age at vaccination was 27-year-old) as dose 2, single for covid-19 immunisation. Vaccine was not administered at military facility. None other additional vaccine was administered on same date of the Pfizer suspect. The patient medical history was not reported. There were no concomitant medications. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot Number: Unknown), via an unspecified route of administration, administered in arm left on 26Jun2021 14:00 (age at vaccination was 27-year-old) as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18Jul2021, the patient was crying as was scared after the second dose of vaccination. On 18Jul2021, evening the patient developed left eye pain. The patient states that on 18Jul2021, night her eye kind of hurt, it felt like a stye coming and she thought that's weird. On 19Jul2021, morning (7:00) when the patient woke up with little swelling to her left eye. The patient also had headache on the 19Jul2021. On an unknown date, the patient states that she googled it and feels it could be normal but was scared it can be an allergic reaction. She wants to know if she should expect this or if it's an allergic reaction. The patient did not visit emergency room and physician office. The outcome of the events was unknown.  Information about lot/batch number not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Chest Pains general soreness all over pain in arms and left shoulder area Weakness sweating problems breathing
got the flu two weeks ago while wearing my mask; Initial information received on 23-Jan-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who experienced got the flu two weeks ago while wearing my mask after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 01-DEC-2022, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (strength, formulation, route, dose: unknown) (lot number and expiry date: not reported) in unknown administration site for Prophylactic vaccination.  On an unknown date the patient developed got the flu two weeks ago while wearing my mask (influenza) (latency: Unknown latency)  I had my flu shot on Dec 1st and got the flu two weeks ago while wearing my mask  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event  At time of reporting, the outcome was Unknown for the event
This spontaneous case, initially received on 20-Dec-2017 from other health professional, concerning a 28-year-old, adult, female pregnant patient of weight 103 lbs and height 61 cm. The patient had no history of pregnancy and concomitant diseases. The concomitant medication included PRENATE MINI. The patient was not tobacco, alcohol or illicit drug user. The patient's last menstrual period was reported as 27-May-2017. On 23-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (batch number: 00644623A, dose, anatomical location, route of administration and expiry date: not reported) at 17th week of pregnancy (explicitly considered as vaccine exposure during pregnancy). The patient had no pregnancy complications. It was reported that there was no evidence of defect/adverse finding from a prenatal test. It was reported that there was no adverse event reported in the pregnant woman and foetus. The estimated date of delivery (EDD) was on 03-Mar-2018. The reporter assessed this case as non-serious.
Onset with chest tightness 10/6/11 mid morning. Red itchy rash 7/7/11 at 0300. On face feet hands arm & legs. Took CLARITIN at 10/7/11 at 0800 no relief took BENADRYL at 0900. Feeling better.
diagnosed with Covid; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was not reported), via an unspecified route of administration on 23Mar2021 as a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Approximately six days later caller was diagnosed with Covid. The patient has appointment to receive her second Pfizer Covid vaccine on 13Apr2021 in which she will be completed her isolation. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 31-AUG-2016, the patient was vaccinated with an improperly stored dose of VAQTA lot # M017982, expiration date 13-SEP-2017 (dose, frequency, route of administration were not reported). The patient's concomitant therapy was not reported. The administered dose of vaccine of exposed to a temperature of 12.2 degree Celsius, for 1 hour 49 minutes. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
Pt recvd DTP/OPV/HIB evening 19APR91 & returned to office w/profound apnea & bradycardia requiring mechanical ventilation 20APR91 @ 930AM; Pt expired 14MAY91 of cardio-respiratory arrest p/transfer there on 20APR91;
1st adverse event on Feb 16th was a testicular infection. this may have been unrelated to the vaccine, but occurred 10 days after the 1st dose.  Then, on Feb 17th my dad had severe chest pressure/pain.  He was admitted to the hospital and diagnosed with Congestive Heart Failure.  His EFR was 35, where a previous test 1 year prior had registered 45-55.
Sore arm 24+ hours slight temperature: 99 degrees Fatigue Muscle soreness in shoulder and neck area Headache
Initial information received on 06-Sep-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case is linked to cases 2018SA255170 and 2018SA254040 (same reporter). This case involves a 45-year-old patient (gender not reported) who received a 0.5 mL expired dose of FLUZONE QUADRIVALENT (lot UI826AC and expiration date 30-Jun-18) once via intramuscular route in the right deltoid on 06-Sep-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was a case of actual medication error due to expired vaccine used. It was not reported if the patient experienced any adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Pfizer-BioNTech COVID-19 Vaccine EUA. Feeling unwell upon waking in the morning at 6:15. Vomiting around 7:30 am and tiredness and decreased appetite until around 9:00 am. Feeling recovered around 10:00 am/12:00 pm.
Pt had her first Covid shot on 03/29/21. She had soreness and slight tenderness in her arm. On 4/11/21 she noticed she was having swelling, redness, warmth, and hardness at injection the site. It sounded similar to "Covid arm". Pt was instructed to use an ice pack, take tylenol/advil, and call the doctor if the swelling or redness got worse. Pt also got bactrim for a UTI on 4/8/21.
Pt returned to pharmacy with swollen/red injection site reaction. It was hot and hard to the touch. She returned two days later (8/15/2014) and it wasn't as red, but the area was wider. The pt also indicated that her arm and side were both swollen.
Nausea fever chills sore arm shoulder. Bad fatique 10 days later and headache
Tremors; This spontaneous case was reported by a non-health professional and describes the occurrence of TREMOR (Tremors) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced TREMOR (Tremors). At the time of the report, TREMOR (Tremors) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no treatment given  no concomitant medication provided
Patient returned to clinic on 10/17/07 for PPD skin test reading right upper arm noted to be redness with rash. Antibiotics given for cellulitis. Patient to return for follow up in 2 days.
Right arm bruised, swollen, itchy, felt like a bee sting. Duration about 10 days. Only treatment was cold compress..
2hrs post vax c/o facial swelling on lt side where inject given; Instructed to go to ER for tx;
Patient received IPV, DTAP, MMR, Prevnar 02/23/2005.  That night Mom took child to ER with nausea and vomiting, fever 102 degrees, red-swollen arm (DTAP site) baseball sized.  Sent home after treatment.  Symptoms persisted and went to doctor's office next day.  Told it was "allergic reaction to DTAP".  Treated with Benadryl and Tylenol.
1 pulmonary embolism in the left lung, 2 pulmonary embolisms in my right lung; a slight pleural effusion in the right lower lung; This is a spontaneous report from a contactable consumer (patient). A 22-year-old female patient received second dose of BNT162B2 (Lot Number: EM9809), via an unspecified route of administration, administered in the left arm on 13Mar2021 14:00 at 22 years-old, as a single dose for COVID-19 immunisation. Medical history included Known Allergies: Penicillin and COVID-19, both on an unknown date. Concomitant medications included ethinylestradiol, levonorgestrel (CAMRESE LO) taken for an unspecified indication, start and stop date were not reported; ergocalciferol (VIT D) taken for an unspecified indication, start and stop date were not reported; escitalopram oxalate (LEXAPRO) taken for an unspecified indication, start and stop date were not reported. The patient previously took amoxicillin, diphenhydramine (BENADRYL), xylometazoline hydrochloride (SUDAFED), guaifenesin and all experienced allergies. The patient previously received first dose of BNT162B2 (Lot Number: EM9809), via an unspecified route of administration, administered in the left arm on 20Feb2021 14:00 at 22 years old as single dose for COVID-19 immunisation. On 05Apr2021 18:00, the patient experienced 1 pulmonary embolism in the left lung, 2 pulmonary embolisms in the right lung and a slight pleural effusion in the right lower lung. The events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care and considered as a Life threatening illness. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of all the events which included Xarelto and Hydrocodone. The outcome of the events was recovering.
Woke up the next morning to blood in my urine.  This has never happened before in my life (and I have had bladder infections before).
Patient felt her chest tight and shortness of breath approximately 16 minutes after vaccinating her against the flu vaccine.  Oxygen was administered for 30 minutes.
Client became lethargic, unresponsive and unable to open eyes. Client was limp. This occurred during last bit of vaccine.
Moderna Covid Vaccine given outside of 12 hour timeframe. Once punctured, the Moderna vaccine fact sheet states that vaccine is usable for up to 12 hours. The vial was first punctured at 1:38 pm on 8/29/22. Covid Vaccine dose given 9 hours past vaccine expiry of 12 hours post initial puncture. No adverse side effects or symptoms experienced by the patient. Vaccine was well kept in temperature monitored refrigerator at all times.
Patient was already in need of Hospice Services and was working toward that designation when he received the second Covid-19 vaccine on the same day that he was accepted into Hospice.  There was no adverse reactions to the vaccine but due to the timing of the events, the Department for  Disabilities asked me to complete this report.
An 18 year old female subject developed nausea and vomiting on the same day she had received a first dose of Menactra.  The event was considered to be non-serious.  No treatment or recovery status information was provided.  Follow up information received on 03/29/2006.  An 18 year old female patient who was taking Prozac at the time of the vaccination, and had no known drug allergies, had received her first intramuscular injection of Menactra, in the right arm and her first intramuscular injection of another Hepatitis A vaccine, in the left arm on 07/27/2005 at approximately 12:00.  150 minutes later, she had a near syncopal episode with weakness, nausea and vomited once.  She presented to the emergency facility and her vital signs were T-98.2, P-43, R-16, and B/P 92/25.  Her standing B/P was 107/55 and her pulse was 80.  Her cardiac, physical/neurological exam was normal.  Her speech was clear and she ambulated with a steady gait.  Her lungs were clear to auscultation and she had no shortness of breath or difficulty swallowing.  She was treated with fluids by mouth and released.  Her final diagnosis was immunization reaction.  It was not reported if the patient had fully recovered from these events at the time of this report.  According to the investigator, the event was related to the study vaccine.